Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Please help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Johnson and Johnson Janssen Xarelto Slaughter
Overstating benefits, downplaying (or not disclosing) risks. Xarelto by Johnson and Johnson Janssen killing people left and right. Lovely, eh?

Keywords: false, marketing, death, dead, xarelto, FDA, lawsuit, Janssen
Date Created/Edited: July 8, 2016
This page has been viewed [an error occurred while processing this directive] times.
 

Most Recent Content....
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
I've already written three pieces regarding the bullshit-based approval of this drug, the known-from-the-beginning risk of patients bleeding out while doing nothing more harmful than eating popcorn while watching a movie. The drug is less effective, more costly and has a higher risk of adverse events - such as stroke and bleeding to death - either downplayed or not disclosed to United States Food and Drug Administration, the Europeans Medicines Agency, The New England Journal of Medicine as well as doctors and patients around the world.
[Xarelto by Johnson & Johnson is Likely Another OverHyped Dud (2012, May 23) hm, seems I was correct, eh?]
[ Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations (2013, July 21)]
[Johnson & Johnson Xarelto, False Marketing, Lawsuits and FDA Says THREE TIMES, "NO EXPANDED USES!" (2014, September 14)]
 
(As of this printing, there are over 7,000 lawsuits filed against Johnson & Johnson / Janssen, which includes 500 dead.)
 
The ROCKET AF study of 15,500 patients using Xarelto, Warfarin or placebo was conducted December 2006 to September 2010. The study results included 3 deaths and 12% dropped out or Johnson & Johnson 'lost track' of them.
 
Helping drive up flood of lawsuits and body count was another wonderful false marketing scam, downplaying risks overstating benefits. On June 6, 2013, the United States Food and Drug Administration (USFDA) sent Johnson & Johnson a warning letter for false advertising. The FDA letter to Johnson & Johnson states,
"The print ad is false or misleading because it minimizes the risks associated with Xarelto and makes a misleading claim."
As the flood of victims grew, the United States Food and Drug Administration stepped in and requested labeling changes for consumer safety. However, most consumers don't re-read (if they even read) consumer safety inserts for drugs after they've already begun a daily dose.
 
Thanks to reporting by the New York Times, it was made public knowledge that there are accuracy concerns regarding the inRatio device used to monitor blood levels throughout the study.
 
I did a quick search in MAUDE - Manufacturer and User Facility Device Experience database for any possible reports of issues with the inRatio device used to monitor blood of patients in the study. I used the parameters: inRatio from December 1, 2005 to December 1, 2006. In the year before the study, over 500 complaints regarding the inRatio device were submitted to MAUDE.
Curious as to WHEN anyone realized there was a flood of reported problems with the device? Or, I think kind of sick and twisted, was this specific device chosen because the accuracy issues would present the results needed to get Xarelto approved? Hm. Twisted - but from a company that continues to sell talc, increasing risk of ovarian cancer by over 30%, to use on baby girls in this country, well, I wouldn't put anything past them at this point.
In 2009, nine United States Food and Drug Administration scientists sent a letter to Barack Obama stating that the medical devices unit of FDA was corrupt,
The purpose of this letter is to inform you that the scientific review process for medical devices at FDA has been corrupted and distorted by current FDA managers, thereby placing the American people at risk.
- they weren't kidding, eh? This is a clear example of depending on accuracy from defective devices with massive complaints that NO ONE did anything about leading to a massive number of deaths and 7,100 (and climbing) lawsuits.
 

 

As the United States Food and Drug Administration starts asking questions regarding the faulty blood monitor, it comes to light that the leader of the ROCKET AF Study of 15,500 patients was the obviously incompetent or corrupt (either way, get the asshole OUT OF FDA) United States Food and Drug Administration Commissioner: Robert 'Xarelto Killer' Califf. Oh boy. Bit of a problem for us, eh?
 
Without any clue that Califf was the leader of the ROCKET AF study which used faulty results from defective equipment to pass a drug he promoted for payment, nominated by President Barack Obama our incredibly dippy senate confirmed Robert Califf as the new United States Food and Drug Administration Commissioner.
 
The New England Journal of Medicine people and victims of Xarelto are a wee bit miffed at Johnson & Johnson for concealing data regarding blood tests done for patients on Warfarin at two points during the ROCKET AF trial. At this point, I haven't found much mention regarding the analysis of that data - if it was ever turned over to regulatory authorities for re-review of approval, or disapproval, of Xarelto. All I got from this is another circle-jerk pointing fingers, Johnson & Johnson claiming they don't know about any data, Bayer claiming they don't know anything about any data, and Duke University whining they just, uh, gee, kinda, sorta forgot about the missing data. Typical, jah?
 
Oh, wait, lest we forget the leader of the Duke University study that sorta forgot about the data regarding additional blood tests, is now the current United States Food and Drug Commissioner; a moron who didn't check the history of the devices chosen for the study and kinda, sorta, forgot about the data has the highest rank in the United States Healthcare System...
 
Isn't that uh, kinda scary to anyone? Wow. just wow.
 
Let's do a quick review of the approval of Xarelto...
The review of data:
- removed three deaths from any consideration
- ignored 12% drop-out or 'lost' patients (data not available for review? hm.)
- study was conducted with data from a device with over 500 complaints in the year prior to the study
- data regarding two blood tests of Warfarin patients with-held from New England Journal of Medicine for review
 
And we wonder why we have yet another killer drug by Johnson & Johnson on the market causing pain and suffering, even death, around the world?
 
Examples of harm by Johnson & Johnson Janssen Xarelto:
Xarelto Lawsuit Filed By Ohio Couple Alleges Damages And Anemia
Plaintiff in Xarelto Lawsuit Suffers Stroke, Dosage may be an Issue
Lawsuit Alleges Xarelto Caused Fatal Internal Bleeding
 
Fatal internal bleeding from a drug to save your life, is, well, a bit excessive when a far safer product, Warfarin, is available.
 
FATAL internal bleeding caused by Xarelto is one of those pesky little risks that were majorly downplayed, and probably not disclosed to those who started taking the drug prior to the new, updated package insert warnings. Basically, the risk of fatal bleeding is huge, because there is no known antidote - no way to turn off the blood-thinning effects for emergencies such as a car accident or if the patient needs emergency surgery.
 
Although Johnson & Johnson's 275 or so subsidiaries are incapable of developing an antidote, five YEARS AFTER FDA approved Xarelto with no known antidote to flood the market, a potential reversal agent may be on the horizon. But for now, if you take Xarelto, don't cut yourself, be involved in a crash or need emergency surgery because, uh, you'll bleed out like a stuck pig on a hot summer day, eh?
 
As Investigations Conducted On Xarelto Clinical Trials As Lawsuit Filings Continue, if you are taking Xarelto, you might want to talk to your doctor about how to safely switch to a not-quite-so-deadly and not-based-on-bad-data-from-a-defective-device and only-if-an-antidote-is-available-please alternative, eh?
 
HELP Needed:
EmilyGifts of support and a kind word are always appreciated. Thank you very much for keeping the site going for the safety of you and your loved ones.
Help is desperately needed to keep this work online.
Thank you, <3 Emily
$.00   

 
Resources:
1. SEC (2016, May). Johnson & Johnson 2016 First 1/4 10-Q. Securities Exchange Commission. Retrieved from https://www.sec.gov/Archives/edgar/data/200406/000020040616000084/a1q10q4-03x16.htm
 
2. Laurence Banville (2016, June 17). Xarelto Lawsuit Plaintiffs Await Bellwether Trials As More Details Emerge About Clinical Trial Data. LegalExaminer. Retrieved from http://newyorkcity.legalexaminer.com/fda-prescription-drugs/xarelto-lawsuit-plaintiffs-await-bellwether-trials-as-more-details-emerge-about-clinical-trial-data/
 
3. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (First received: November 23, 2006; Last updated: April 10, 2014). An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation. Clinical Trials.gov, A service of the U.S. National Institutes of Health. Retrieved from https://clinicaltrials.gov/ct2/show/NCT00403767
 
4. Anna Yukhananov (2012, May 21). FDA staff sends mixed message on J&J drug Xarelto. Reuters. Retrieved from http://www.reuters.com/article/us-fda-johnson-xarelto-idUSBRE84K0M220120521?feedType=RSS&feedName=healthNews&utm_source=twitterfeed&utm_medium=twitter&utm_campaign=Feed%3A+reuters%2FhealthNews+%28Reuters+Health+News%29
 
5. Zarna Patel and Amy Toscano (2013, June 6). FDA WARNING LETTER. Office of Prescription Drug Promotion, United States Food and Drug Administration. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM357833.pdf
 
6. Staff Writer (2016, June 10). Xarelto (Rivaroxaban) Tablet, Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)s. U.S. Food and Drug Administration. Retrieved from http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm367392.htm
 
7. KATIE THOMAS (2016, MARCH 17). Accuracy Concerns on Testing Device for Blood-Thinning Drug. New York Times. Retrieved from http://www.nytimes.com/2016/03/18/business/accuracy-concerns-on-testing-device-for-blood-thinning-drug.html?_r=0
 
8. MAUDE - Manufacturer and User Facility Device Experience (monitored). MAUDE search form. United States Food and Drug Administration. Retrieved from http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Search.cfm
 
9. MAUDE - Manufacturer and User Facility Device Experience (2016, July 10). MAUDE search results. United States Food and Drug Administration. Retrieved from http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/results.cfm?start_search=1&productcode=&productproblem=&devicename=&modelNumber=&reportNumber=&manufacturer=&brandname=inratio&eventtype=&reportdatefrom=12%2F01%2F2005&reportdateto=12%2F1%2F2006&pagenum=10
 
10. Certified Letter from Food and Drug Administration to President Obama (2009). Certified Letter from Food and Drug Administration to President Obama. United States Food and Drug Administration. Retrieved from http://www.johnsonandtoxin.com/data/cert-fda-letter-to-the-president-4-2-09-and-trans-team-1-7-09.pdf
 
11. KATIE THOMAS (2016, February 22). F.D.A. Asks If Faulty Blood Monitor Tainted Xarelto Approval. New York Times. Retrieved from http://www.nytimes.com/2016/02/23/business/fda-asks-if-faulty-blood-monitor-tainted-xarelto-approval.html?_r=0
 
12. Emily Patterson (2016, March 2). New United States Food and Drug Commissioner Dr. Robert Califf Responsible for KILLER Xarelto. Johnson And Toxin. Retrieved from http://www.johnsonandtoxin.com/califf_fda_commissioner.shtml
 
13. Emily Patterson (updated index). Obama Files. Johnson And Toxin. Retrieved from http://www.johnsonandtoxin.com/obama.shtml
 
14. Brady Dennisn (2016, February 24). Senate confirms Robert Califf as new FDA commissioner. Washington Post. Retrieved from https://www.washingtonpost.com/news/to-your-health/wp/2016/02/24/senate-confirms-robert-califf-as-new-fda-commissioner/
 
15. KATIE THOMAS (2016, MARCH 1). Document Claims Drug Makers Deceived a Top Medical Journal. New York Times. Retrieved from http://www.nytimes.com/2016/03/02/business/document-claims-drug-makers-deceived-a-top-medical-journal.html?_r=0
 
16. Bill Berkrot (2015, November 11). Portola reversal agent for Xarelto succeeds in late stage trial. Reuters. Retrieved from http://www.reuters.com/article/us-health-heart-portola-idUSKCN0T01WN20151111
 
17. Laurence Banville (2016, June 1). Investigations Conducted On Xarelto Clinical Trials As Lawsuit Filings Continue. Legal Examiner. Retrieved from http://newyorkcity.legalexaminer.com/fda-prescription-drugs/investigations-conducted-on-xarelto-clinical-trials-as-lawsuit-filings-continue/
 

 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries